Literature DB >> 7803928

Serovars of Plesiomonas shigelloides.

E Aldová1.   

Abstract

Among 391 P. shigelloides strains, 330 were typable and found to belong to 43 O serovars. The most frequent O serovars were O17 (23%), O32 (7%), O12 (4.5%) and O5, O18 and O44 (3.8% each). The majority of the serovars represented, with almost 300 strains, were sporadically found in very distant countries of three continents (Europe, Asia, America), whereas only one serovar (O68) was isolated three times in one single district of South Bohemia (Ceské Budéjovice). It suggests that such an incidence of plesiomonads is only seemingly sporadic and that there must be many strains which are not detected owing to the imperfect cultivation methods used so far.

Entities:  

Mesh:

Year:  1994        PMID: 7803928     DOI: 10.1016/s0934-8840(11)80635-3

Source DB:  PubMed          Journal:  Zentralbl Bakteriol        ISSN: 0934-8840


  4 in total

1.  Comparison of O-antigen gene clusters of Escherichia coli (Shigella) sonnei and Plesiomonas shigelloides O17: sonnei gained its current plasmid-borne O-antigen genes from P. shigelloides in a recent event.

Authors:  J G Shepherd; L Wang; P R Reeves
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

2.  Molecular evidence of Plesiomonas shigelloides as a possible zoonotic agent.

Authors:  Carlos González-Rey; Anja Siitonen; Alona Pavlova; Ivan Ciznar; Stefan B Svenson; Karel Krovacek
Journal:  Folia Microbiol (Praha)       Date:  2011-05-17       Impact factor: 2.099

3.  Potential virulence-associated properties of Plesiomonas shigelloides strains.

Authors:  I Ciznár; A Hostacka; C Gonzalez-Rey; K Krovacek
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

4.  Core oligosaccharide of Plesiomonas shigelloides PCM 2231 (Serotype O17) lipopolysaccharide--structural and serological analysis.

Authors:  Anna Maciejewska; Jolanta Lukasiewicz; Marta Kaszowska; Aleksandra Man-Kupisinska; Wojciech Jachymek; Czeslaw Lugowski
Journal:  Mar Drugs       Date:  2013-02-06       Impact factor: 5.118

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.